An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome

Status:
Active, not recruiting

Trial end date:
2022-01-01

Target enrollment:

Participant gender:

This is an international, multicenter, open-label, long-term safety study of ZX008 in subjects with Dravet syndrome.

Phase 3

Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.

Fenfluramine